Meal Timing Supercharges Exercise Through Fat-Muscle Metabolic Crosstalk
New research reveals how when you eat reshapes adipocyte signaling to boost endurance — and identifies a druggable target to mimic the effect.
Summary
Researchers at Army Medical University found that day-restricted feeding (DRF) optimizes exercise performance by activating AMPKα2 signaling in fat cells, which coordinates circadian metabolic rhythms between adipose tissue and skeletal muscle. Using multi-omics in mice, they showed DRF remodels the mitochondrial proteome and lipidome of white adipose tissue and alters circulating metabolites like lactate and succinate. Knocking out adipocyte AMPKα2 impaired endurance and disrupted muscle clock genes. Crucially, an oral AMPK activator (C29) boosted muscle endurance only when given at the right time of day and required intact adipocyte AMPKα2 — suggesting meal timing and pharmacology can be combined to enhance physical performance.
Detailed Summary
Meal timing has long been associated with metabolic health, but the precise biological mechanisms linking when we eat to how well we exercise have remained elusive. This study provides a detailed mechanistic answer, placing adipocyte AMPKα2 signaling at the center of a fat-to-muscle communication axis that is gated by circadian rhythms.
The research team used day-restricted feeding (DRF) protocols in mice, combined with phosphoproteomics, proteomics, and lipidomics to map how feeding timing reshapes biology in gonadal white adipose tissue (GWAT). They found that DRF orchestrates diurnal oscillations in the mitochondrial proteome, neutral lipidome, and key nutrient-sensing pathways within fat cells — changes that prime the body for better physical performance.
Central to these effects is AMPKα2, encoded by Prkaa2 in adipocytes. Adipocyte-specific knockdown of this gene blunted physical endurance in mice, disrupted rhythmic expression of acyl-CoA metabolism genes, abolished lipidome rhythmicity in GWAT, and altered circadian patterns of serum metabolites — particularly lactate and succinate, both critical fuels and signals during exercise. Importantly, adipocyte AMPKα2 also regulated muscle clock gene expression, demonstrating a direct fat-to-muscle signaling axis.
The translational highlight is the AMPK activator compound C29, which enhanced endurance and muscle function only when administered at a specific time of day, and only when adipocyte AMPKα2 was intact. This time-of-day dependency underscores that the benefit is genuinely circadian, not simply pharmacological.
For longevity and performance medicine, this work suggests that aligning meal timing with exercise schedules — and potentially using circadian-aware AMPK-activating compounds — could meaningfully enhance muscle function and metabolic resilience, with implications for aging populations where both muscle loss and circadian disruption are common.
Key Findings
- Day-restricted feeding remodels the adipose mitochondrial proteome and lipidome in a circadian pattern, boosting exercise readiness.
- Adipocyte-specific AMPKα2 knockout impairs physical endurance and disrupts circadian lipid and metabolite rhythms.
- Serum lactate and succinate — key exercise metabolites — lose normal circadian oscillation when adipocyte AMPKα2 is absent.
- Adipocyte AMPKα2 regulates muscle clock genes, establishing a fat-to-muscle circadian signaling axis.
- AMPK activator C29 enhances endurance only at the correct time of day and requires intact adipocyte AMPKα2 signaling.
Methodology
Mouse models were used with day-restricted feeding protocols and adipocyte-specific Prkaa2 knockdown. Multi-omics approaches including phosphoproteomics, proteomics, and lipidomics were applied to gonadal white adipose tissue. Pharmacological validation used oral administration of AMPK activator C29 at varying times of day.
Study Limitations
The study was conducted entirely in mice, and translation to humans requires validation given differences in circadian biology and adipose tissue physiology. Only gonadal white adipose tissue was examined, leaving other fat depots unstudied. The abstract does not detail whether C29's effects were tested in aged animals or metabolically compromised models most relevant to longevity.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
